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Abstract: Attempts to optimize monitoring of brace adherence prescribed to adolescents with
idiopathic scoliosis (IS) have generally relied on sensors. Sensors, however, are intrusive and do not
allow the assessment of psychological and physical consequences of brace use that might underlie
poor adherence. Mobile applications have emerged as alternatives to monitor brace compliance.
However, the feasibility and utility of these app-based systems to assess key psychological and
physical domains associated with non-adherence remain unexplored. This feasibility study aims to
test the usability, acceptability, and clinical utility of an app-based system that monitors brace use
and related psychological and physical factors. Forty adolescents with IS daily respond to the app for
90 days. The patient responses may generate clinical alarms (e.g., brace non-adherence, discomfort,
or distress) that will be sent daily to the medical team. Primary outcomes will be app usability,
acceptability, and response rates. Secondary outcomes will include brace adherence, the number of
side effects reported, number and type of clinical alarms, stress, quality of life, perceived health status,
and mood. If accepted by patients and clinicians, apps may allow rapid detection and response to
undesired events in adolescents undergoing brace treatment.
Keywords: adolescent idiopathic scoliosis; Information and Communication Technologies; mobile
application; brace adherence; treatment effectiveness
1. Introduction
Scoliosis is defined as a torsional deformity in the shape and position of the spine,
the thorax, and the trunk, which is generally diagnosed when the Cobb angle, a measure of
the spinal deformity, is equal to or higher than 10◦ [1]. In particular, idiopathic scoliosis (IS)
refers to scoliosis that occurs in apparently healthy patients without a clear agent causing
the deformity [1]. IS affects 2–3% of adolescents, although it can also occur in newborns.
According to the age at which the diagnosis is made, IS can be classified into infantile
(0–2 years old), juvenile (3–9 years old), adolescent (Adolescent Idiopathic Scoliosis, AIS;
10–17 years old), or adult (from the age of 18) [1]. The most notable progression of IS
occurs at the beginning of puberty (11–14 years), which has been associated with the faster
development of the spinal curvature that takes place in this period [1]. In addition to
Int. J. Environ. Res. Public Health 2021, 18, 7767. https://doi.org/10.3390/ijerph18157767 https://www.mdpi.com/journal/ijerph
Int. J. Environ. Res. Public Health 2021, 18, 7767 2 of 22
age, IS can also be classified according to the severity of the deformity, measured with
the Cobb’s degrees (Low = up to 20◦; Moderate = 21◦–35◦; Moderate-severe = 36◦–40◦;
Severe = 41◦–50◦; Severe-very severe = 51◦–55◦; Very severe = over 56◦) [1].
IS is often unrelated to medical complications (e.g., pain or other health-related
problems) [2,3]. However, even in less severe curves, the deformity can negatively impact
the psychological wellbeing of individuals (e.g., depression symptoms and self-esteem)
and can be associated with an increase in psychological problems, such as substance abuse
and suicidal ideation [4,5], which justifies the need for adequate treatment. Wearing a
brace is a conservative treatment for IS that often helps avoid surgery, improves aesthetics,
and increases quality of life [1]. Brace treatment consists of the application of an external
mechanical force, the objective of which is to correct the spinal deformity. The brace exerts
compression forces on the convex side, distraction forces on the concave side, transverse
forces on both sides, and lateral bending on the convex side [6]. The brace is especially
recommended when the curvature is between 30◦ and 40◦ or between 20◦ and 29◦ with a
progression of more than 5◦ in the last year [7]. In fact, when scoliosis angles are greater
than 30◦, the deformity becomes evident and disability, pain, and functional limitations
increase significantly [1,8]. Next, depending on the severity of the case, the brace can be
prescribed only at night (8–12 h a day), part-time (12–20 h a day), or full time (20–24 h a
day) [1].
Review studies have revealed promising results regarding the effectiveness of braces
in treating AIS. However, there is insufficient scientific evidence to recommend their
use [9], probably due to the low adherence rates associated with brace use, which tend to
be exaggerated when retrospectively evaluated [1]. Adherence to the use of the brace is
in fact one of the most important factors negatively influencing the effectiveness of this
orthopedic treatment [10]. Two factors that have been argued to explain non-compliance
with these orthopedic treatments are (a) the appearance of unwanted effects associated
with the use of braces (e.g., pain, scuffing, or discomfort sleeping) and (b) the psychological
distress and general beliefs related to the deformity (i.e., “I don’t care about my back”) and
its treatment (i.e., “I think people can see the brace under my clothes”) [11,12]. Different
efforts have been conducted to improve the adherence to the brace. For example, brace
monitoring has been proposed to improve brace compliance [13]. For this reason, it has
been argued that there is a need to actively involve patients during the whole treatment
process [14], including monitoring of outcomes and brace compliance [1].
Traditionally, brace adherence has been explored retrospectively [15]. This is problem-
atic because it does not guarantee the security of the treatment, it does not provide reliable
data, and it is an inefficient methodology. First, retrospective assessments do not allow the
detection of undesired events in the real context and when they occur, but later when pa-
tients have a face-to-face medical appointment. As a consequence, the patient must decide
what to do when they experience unwanted side effects [16], which compromises the safety
of the intervention. For example, an adolescent may decide to immediately stop wearing
the brace when they experience pain or itching and therefore would not receive treatment
until the next appointment at the clinic (which can occur weeks or months later, depending
on waiting lists). Conversely, another patient may decide to tolerate the discomfort and
continue wearing the brace despite unwanted side effects until the next appointment with
their doctor, which can lead to undue suffering. Therefore, leaving the decision on when
and in the presence of which symptom adolescents should respond to and how they should
respond can be problematic. Regarding the second point, which refers to the reliability
of the data, research has shown that retrospective assessments are not free from recall
bias. In particular, more severe symptoms tend to be reported when health conditions are
retrospectively assessed [17]. In the specific case of brace monitoring, it is unlikely that
patients will be able to remember the exact number of hours and days that they have been
wearing the brace for a given period of time. It is also unlikely that adolescents will be
able to remember all the side effects they experienced in the different contexts in which
they occurred. The latter point refers to treatment efficiency. Retrospective evaluations are
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not efficient as they do not allow early detection of noncompliance with brace treatment
and psychological distress related to brace use (i.e., irrational beliefs, intense unpleasant
emotions, or lack of social support). Therefore, early interventions cannot be delivered
in response to these, which means that the patients’ quality of life may be affected. This,
in turn, could result in more lasting and severe symptoms (i.e., brace-related side effects,
anxiety, and depressive symptoms), ultimately resulting in higher personal and financial
costs (i.e., recurrent visits and contacts with health services).
The electronic monitoring of brace compliance has emerged as a possible solution to
overcome the aforementioned shortcomings found in IS monitoring. The most commonly
used devices to assess brace compliance are temperature and force sensors [13]. Some
promising findings have already been reported with these devices. For example, patients
are more likely to wear the brace when they know that they are being monitored to
avoid professional criticism [18] and sensors have been described as non-invasive [19].
While acknowledging this, it has also been argued that adolescents may perceive that they
are being controlled and judged by using these passive assessment devices, and some
authors have expressed concern about how sensors may negatively affect the doctor–
patient relationship [20]. Furthermore, the sensors are designed to assess isolated brace
compliance, but the assessment of other important psychosocial variables related to the
brace (e.g., irrational beliefs, intense unpleasant emotions, or lack of social support) cannot
be evaluated with the sensors.
During the last decades, the use of the Internet and mobile devices in our daily
activities has increased dramatically, especially in adolescents [21,22]. The widespread
use of these technologies has reached the healthcare context to improve both physical and
psychological functioning [23,24]. In the specific context of AIS, web and mobile devices
have been postulated as a useful alternative to sensors in the diagnosis and monitoring
of AIS. For example, mobile applications have been used as screening tools for AIS to
measure the Cobb’s degrees of curvature, even more accurately than traditional hand-held
scoliometers [25]. Another alternative to sensors has been a web-based system for assessing
brace compliance, which was well accepted by the participants [26]. Some limitations of the
literature on alternatives to sensors for IS assessment should be considered. First, the daily
measurement of how braces can affect physical activities and psychological wellbeing has
not yet been included in these monitoring systems. Second, to date, patients or parents
have been requested to log into a web system and upload the brace usage data at least once
a day. This system has some limitations compared to apps, as the former requires Internet
access and cannot use specific triggers such as a push system to start the survey.
It might be reasonable to think that the inclusion of an app-based monitoring system
in clinical settings can help overcome the barriers of traditional, retrospective face-to-face
assessments, and electronic devices (i.e., sensors and web pages). In the present study,
we aim to test the feasibility and clinical utility of a new app-based management method.
With this app, we intend to improve the monitoring of brace adherence, as well as the
psychological and physical status of patients with AIS. Regarding feasibility, this study
aims to explore the extent to which patients (adolescents with IS) and physicians accept
the use of an app for daily monitoring. In relation to clinical utility, the objective of this
work is to test whether the app detects adherence problems with the brace and related side
effects and the clinicians respond quickly to them. We anticipate that the implementation
of the app will be feasible for AIS monitoring (high acceptability and adherence to the
app). In addition, we expect to find some indicators of the potential usefulness of the
app (e.g., rapid detection of brace adherence problems and psychological and physical
complications that allow a quick response by the medical team).
2. Materials and Methods
The current study uses a single group open trial design. In this feasibility study, we will
monitor the use of brace and several outcomes related to brace use (e.g., psychological
and physical status in relation to the brace) in a sample of adolescents with IS who are
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cared for in the Physical Medicine and Rehabilitation Service of a public tertiary hospital in
Spain (Vall d’Hebron University Hospital). All adolescents who meet the inclusion criteria
will be offered a mobile application for scoliosis monitoring. This app-based monitoring
involves a daily evaluation for 90 days (3 months). Additionally, the assessment protocol
includes two measurement points: before the brace use (baseline) and after three months
of brace use (end of the study). These assessments (e.g., baseline and end of study) will
be conducted using the Qualtrics online platform. The Ethics Committee of the Vall
d’Hebron University Hospital approved the study and all its procedures. The Ethics
Committee mentioned above aims to protect the safety of clinical trial participants and
to ensure that there are no deviations from the expected plan. This study was previously
registered in Clinicaltrials.gov (NCT04881591) on 10 May 2021. A standard Protocol Items
Recommendations for Interventional Trial (SPIRIT) was followed to inform the protocol of
the present study (Appendix A).
2.1. Participants
The participants included in this feasibility study will be 40 adolescents with IS. Sam-
ple size has been calculated according to previous recommendations suggesting a minimum
of 30 participants in feasibility and pilot studies [27] and a minimum of 15 participants
in usability studies with devices used in healthcare settings [28]. Sample size calculation
includes a conservative correction of 20% for attrition.
Inclusion criteria:
• Age between 10 and 18 years when the brace is prescribed, Risser 0–2 and, if female,
either before menarche or less than 1 year after menarche
• Primary curve angles 25◦–40◦.
• No prior brace treatment.
• The patient has a mobile phone with an Android or iOS operating system.
• The patient has the physical ability to use the mobile application.
• The patient does not present a serious psychological and/or cognitive problem or
language alterations.
• Signed informed consent.
• Exclusion criteria:
• Not having a mobile phone or having a mobile phone with incompatible characteristics
(i.e., unable to download the app).
• The patient has cognitive impairment or language problems to understand the use of
the app and/or answer its questions.
• The patient has a serious mental health or substance abuse problem.
2.2. Recruitment and Procedures
Participants will be adolescents attending the Physical Medicine and Rehabilitation
Service at Vall d’Hebron University Hospital who have been prescribed a brace for their IS.
Participants who meet inclusion criteria (including their parents if participants are under
18 years of age) will receive the study information sheet (see Appendix B). If they give their
voluntary consent to participate, they will be asked to sign the written informed consent
(see Appendix B). Once the diagnosis is made by a physician from the Physical Medicine
and Rehabilitation Service, patients with IS are prescribed a brace. Patients are asked to
obtain the brace from an orthopedic center within the following week and are asked to test
the brace for a few hours daily, mostly overnight, for a couple of weeks. This test period is
used to verify if adjustments to the brace are required before a final version of the brace is
provided and prescribed full time. An on-site consultation at the Physical Medicine and
Rehabilitation Service is set to make these adjustments. This is the time when the app is
also downloaded because it is at this stage that the final version of the brace is prescribed
full time and on-site appointments become less frequent.
This recruitment session is used to conduct the baseline assessment and download the
app. A trainee hired for the present study will assign a unique anonymous alphanumeric
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code to patients (see Appendix C) that is linked to their identifying information (medical
record number) in a separate document. This alphanumeric code is used to identify
patients in both online and app assessments. The participants are asked to respond to
a baseline assessment with Qualtrics. Their responses do not contain any identifying
information. This evaluation includes sociodemographic data (i.e., age, sex, nationality),
as well as scoliosis-related variables (i.e., stress, quality of life, perceived health, anxiety,
and depressive symptoms). The trainee then helps the participants to download the app
and explain to them how to use it daily for the next 90 days. After this period, a follow-up
appointment is arranged to administer the end-of-study evaluation, again with Qualtrics.
Figure 1 shows the study schedule.
Figure 1. Study timeline.
2.3. Usual AIS Treatment + App-Based Ecological Momentary Assessment
In addition to the app, all adolescents receive the usual treatment for scoliosis that
is provided in the Physical Medicine and Rehabilitation Service during the study period
(90 days), that is, they are prescribed the daily use of a brace. In terms of monitoring,
routine practice in the unit only includes a face-to-face assessment 3 months after the final
version of the brace is prescribed, which means that problems with this final version of
the brace are traditionally assessed retrospectively. Therefore, to minimize the problems
associated with relying only on retrospective and episodic evaluations, the present study
incorporates a daily app-based monitoring during 90 days since the start of brace treatment,
which is a critical period in which the physical and psychological adaptation to full-time
use of the brace might be more challenging.
The Pain Monitor app is a mobile application whose contents have been adapted to
conduct ecological momentary assessments (EMA) in different health conditions. It has
been previously validated in chronic pain conditions [29] and has received several awards
since then (https://www.consalud.es/saludigital/145/premios-saludigital-2019-recon
ocen-mejores-iniciativas-tecnologia-sanitaria_60524_102.html, accessed on 11 July 2021).
It is currently available for free in the Android (https://play.google.com/store/apps/d
etails?id=monitorinvestigacion.code, accessed on 3 July 2021) and iPhone (https://apps
.apple.com/es/app/monitor-de-dolor-multic%C3%A9ntrico/id1546241257, accessed on
3 July 2021) stores. The app evaluates important brace-related physical and psychological
domains, namely side effects of the brace, pain intensity, mood, brace interference, brace
adherence, avoidance behavior, discomfort, and social support. Following the procedure
of a similar investigation [29], to create the EMA assessment protocol, a multidisciplinary
team of psychologists and physicians revised the most frequent assessment tools in the
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AIS literature and selected the most representative constructs to create a representative,
but short set of items (see a detailed description in Appendix D).
Participants respond daily to the questions in the app. They are prompted in the
afternoon (at 7 pm) and have 2 h to respond (until 9 pm). If participants do not respond to
the assessment by 8:30 p.m., a second reminder is sent. If participants access the application
after 9 p.m., they are not allowed to complete the daily assessment, which is treated as
missing data, and participants are instructed to access to the app the next day at the
scheduled time. This is done to avoid backfilling and non-ecological assessment. EMA
involves the assessment of the current or very recent status of patients [30]. If participants
were allowed to respond to the daily assessments later than 9 p.m., this would compromise
the ecological nature and comparability of the assessments. After 3 days of app non-
compliance, the app sends a notification to the doctors, and they will call the patients to
encourage compliance with the app.
Clinical alarms are generated in the app according to certain preset unwanted events
(see Table 1). Every working day, the physicians will receive an anonymous report that
will contain only the alphanumeric code described above, together with the description
of the alarm. Next, the physicians access the document where the alphanumerical code is
linked with the medical record number (Appendix C) to check the clinical history of the
patients and decide the type of action necessary to solve the clinical alarm. Clinical alarms
are not an emergency service and patients should use the services they usually use (i.e.,
emergency services, primary care, call to the Physical Medicine and Rehabilitation Service,
etc.) in case they are faced with any symptom that worries them.
Table 1. Pre-specified clinical alarms detected by the mobile application.
Domain Clinical Alarms Recommendations 1
Side effects
Pressure pain 3 consecutive days Call the patient
Friction pain 3 consecutive days Call the patient
Excessive heat/sweating 7 consecutive days Call the patient
Movement difficulties 3 consecutive days Call the patient
Teased by peers/relatives 4 consecutive days Psychoeducation
Pain
Pain intensity ≥3 during 3 consecutive days Call the patient
Emotions
Sadness 5 consecutive days Psychoeducation
Anxiety 5 consecutive days Psychoeducation
Anger 5 consecutive days Psychoeducation
Shame 5 consecutive days Psychoeducation
Overwhelm 5 consecutive days Psychoeducation
Frustration 5 consecutive days Psychoeducation
Interference
Sleeping 3 consecutive days Call the patient
Basic movements 3 consecutive days Call the patient
Relationships (friends) 5 consecutive days Psychoeducation
Relationships (relatives) 5 consecutive days Psychoeducation
Leisure activities 5 consecutive days Psychoeducation
Academic activities 5 consecutive days Psychoeducation
Mood 5 consecutive days Psychoeducation
Dressing 5 consecutive days Psychoeducation
Self-image 5 consecutive days Psychoeducation
Motivation for going out 3 consecutive days Psychoeducation
Avoid talking about the brace ≥7 during 7 consecutive days Psychoeducation
Avoid activities/being with others ≥5 during 5 consecutive days Psychoeducation
Overall physical discomfort ≥5 during 5 consecutive days Call the patient
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Table 1. Cont.
Domain Clinical Alarms Recommendations 1
Brace adherence
Morning only (8–14 h) 7 consecutive days Call the patient
Afternoon only (14–19 h) 7 consecutive days Call the patient
Sleeping only (last night) 7 consecutive days Call the patient
Morning and afternoon only 7 consecutive days Call the patient
Sleeping and morning 15 consecutive days Call the patient
Sleeping and afternoon 15 consecutive days Call the patient
No use of the brace 3 consecutive days Call the patient
Poor social support
Friends 5 consecutive days Psychoeducation
Family 5 consecutive days Psychoeducation
Teachers 5 consecutive days Psychoeducation
Other people 5 consecutive days Psychoeducation
1 The physician may change the recommended action according to the patient’s condition.
2.4. Physical Medicine and Rehabilitation Service Support According to Clinical Alarms
As reported in Table 1, each alarm generated by the app triggers a response from
the medical team. This includes calling the patient (e.g., in the presence of intense and
persistent pain) or sending the patient psychoeducational content by mail (see an example
in Appendix E). This document has been created by a team of four psychologists trained
in Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for health
problems and includes components of both types of interventions. Since the unit where the
brace treatment is delivered does not have a psychologist, this content has been created to




• The usability and acceptability of the app will be assessed by both patients (end users)
and clinicians (relevant stakeholders). In the patients, this is evaluated both objectively
and subjectively. To obtain an objective feasibility result, we calculate the adherence
with the app by dividing the number of completed assessments by the number of
planned evaluations and provide the response rate. To obtain a subjective measure of
usability and acceptability, at the end of the study period (3 months after the first use
of the app), we administer the System Usability Scale (SUS) [31] using an online survey
tool that will be sent by mail (Qualtrics). In the clinicians, the acceptability of the new
app-based monitoring method is evaluated using an assessment protocol developed
for a similar earlier study [16]. As reported in Appendix D, this includes items that
are consistent with the technology acceptance model [32], including perceived utility,
acceptability, and intended use. This will be evaluated at the end of the study with the
Qualtrics online survey tool anonymously.
Secondary outcomes measures:
Assessed by the Pain Monitorapplication (all once daily from 7 p.m. to 9 p.m.):
• Brace adherence: Ad hoc self-reported item: “When have you been able to wear the
brace since you went to bed yesterday?” Response options cover all daily periods
(morning only, afternoon only, only for sleeping, or any combination of these). To avoid
bias due to socially desirable responses, honesty will be encouraged both during
recruitment and in the informed consent.
• Treatment safety: An ad hoc question has been created including the most frequent side
effects of brace use according to the literature [10,12] and the authors’ clinical expertise.
These include: pain due to pressure, pain due to friction, excessive heat/sweating,
movement difficulties, and being teased by peers or close ones.
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• Clinical alarms: in addition to the assessment of brace adherence and side effects,
several items were adapted from validated questionnaires (Appendix D) to assess pain
intensity, unpleasant emotions, interference, avoidance, discomfort, and social support
daily. Clinical alarms will be automatically generated and sent to the physicians by
the app depending on the patients’ responses to these items (Table 1).
Assessed at baseline and at the end of the study with the Qualtrics online platform
(see Appendix D for a detailed instrument description):
• Stress is measured with the Sobberheim Stress Questionnaire-Brace (BSSQ-Brace) [33,34].
• The Patients’ health-related quality of life is measured with the Italian Spine Youth
Quality Of Life (ISYQOL) [35,36].
• Perceived health status is measured with the Scoliosis Research Society -22 (SRS-
22) [37,38].
• Anxiety and depressive symptoms is measured with the Hospital Anxiety and De-
pression Scale (HADS) [39,40].
2.6. Ethics and Protection Data
The authors state that all the procedures included in this work comply with the ethical
standard of the relevant national and institutional committees on human experimentation
and with the Helsinki Declaration [41]. All the procedures described in this work were
approved by the ethical committee of the Vall d’Hebron University Hospital. Modifications
in the protocol are communicated to the ethical committee of the aforementioned hospital.
The responses provided by both assessment tools, namely Qualtrics and the app,
are completely anonymous. Data collection and storage follow the Spanish law and
data protection rules (“Ley Orgánica 3/2018, de 5 de diciembre, de Protección de Datos
Personales y garantía de los derechos digitales”) [Spanish Data Protection Law], as well
as Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April
2016 and Directive 95/46/EC (GDPR) on the protection of personal data and on the free
movement of such data. Qualtrics® is in accordance with the new General Data Protection
Regulation (GDRP), is ISO 27,001 certified, and FedRAMP authorized. In addition, it allows
correction, modification, and suppression of personal data in a permanent way (https:
//www.qualtrics.com/uk/platform/gdpr/ accessed on 11 May 2021).
If authorized by the patient in the informed consent form, the external researcher
responsible for the study (Dr. Carlos Suso Ribera) has access to their personal information
(i.e., phone number) to contact them and solve app-related technical issues (e.g., the app
is not working or was deleted by mistake and needs to be reinstalled). These actions are
recorded and reported as potential barriers for future implementation and acceptability
of the new monitoring method. The study and its procedures are not associated with
clinical complications or harmful effects. All participants may voluntarily suspend their
participation in the study at any point. Their IS treatment and doctor–patient relationship
will not be compromised by the discontinuation of the study.
3. Data Plan Analyses
Data are analyzed using intention-to-treat principles. Descriptive data (means, stan-
dard deviation, and frequencies) are reported for all study variables. These include usability
and acceptability and response rates in the app (primary outcomes), together with brace
adherence, the number of side effects, the number and type of clinical alarms generated by
the app, stress, quality of life, perceived health status, and mood (secondary outcomes).
Statistical differences between completers and non-completers are calculated. Completers
are those who respond to at least 85% of the requested daily assessments, which is the
average completion rate in EMA revealed in past meta-analytic research [42]. Adolescents
who provide less than 85% responses to the app are considered non-completers.
Regarding feasibility, app adherence is calculated by dividing the number of responses
registered in the app and the number of assessments programmed in the app (90 assess-
ments, once daily during the whole study).
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In relation to the clinical utility of the app, brace adherence is calculated by dividing
the number of hours of use reported by the prescription they were given, as suggested in
previous research [43]. Low brace adherence serves as a clinical alarm (Table 1). Changes
in the remaining secondary measures (i.e., stress, perceived quality of life, perceived health
status, and mood) from baseline to end of study are also explored, although it is expected
to find minimal changes because these are not the main aim of the present study.
The results derived from the statistical analyses described above will be reported in
the form of tables, graphs, and flowcharts. All the analyses are performed separately by the
lead researcher and an independent researcher. An interim analysis is planned at the end
of the study once 50% of the total sample has been evaluated. All coauthors and the Ethics
Committee of the Vall d’Hebron University Hospital have access to these analyses and
are allowed to participate in the decision to terminate the trial. The database is available
under reasonable request for any researcher who requests it. Personal information from
the participants is not included in this data set. The results from this feasibility study will
be published anonymously in international journals and conferences.
4. Discussion
IS is a prevalent health condition that usually appears during adolescence due to
the development of the spine that occurs at puberty [1,44]. IS can have a negative impact
on psychological wellbeing, quality of life, disability, and physical health status, so early
detection and treatment are essential [1,4,5,8]. The brace can be effective in the treatment
of IS. However, its efficacy has also been questioned due to low adherence rates [9]. In an
effort to improve brace compliance, studies have conducted retrospective assessments to
investigate adherence and the factors that may negatively influence it [15]. Unfortunately,
this methodology has a limited impact on the safety and effectiveness of treatment be-
cause assessment is conducted long after problems have arisen and is based on recall and
memory, often leading to bias [17]. Additionally, face-to-face assessments require traveling
(sometimes long distances), which increases costs and burden for patients (and their fami-
lies). Electronic assessments can help overcome the limitations of retrospective face-to-face
episodic assessments. Due to the widespread use of web and app-based devices in our
daily activities, it seems feasible to integrate these devices into the daily monitoring of IS
in adolescent populations. Some web and mobile applications have been used previously
in detection of AIS and the assessment of adherence to the brace [25,26]. However, the
assessment of the psychological and physical state of the patient, which could explain
individual differences in adherence and provides important information for the safety
and effectiveness of the treatment, has been never included in the daily monitoring of
adolescents with IS.
The present protocol described a feasibility study whose aim is to test the usability,
acceptability, and clinical utility of an app-based system for the monitoring of adolescents
with IS who use a brace. Specifically, we hope to provide new insights into the feasibility
of the app (i.e., app adherence and usability), as well as into its utility in detecting non-
compliance with brace (treatment adherence), brace-related side effects like pain and
interference in sleep (treatment safety), and psychological distress associated with wearing
the brace (i.e., intense unpleasant emotions and poor social support). Regarding feasibility,
we expect to find high compliance rates with the app-based monitoring system in the end
users. Non-adherence to the app will generate clinical alarms, so the professional will
be able to contact the participants to encourage them to interact with the app. For this
reason, we expect to find low attrition rates during the study period (90 days). Additionally,
in relation to the feasibility results, we anticipate that the participants will be very satisfied
with the app in terms of acceptability and usability (i.e., “I needed to learn many things
before I could start using the system”). Based on previous similar research [45,46], we also
anticipate that the clinicians will be satisfied with the app in terms of perceived utility,
low burden, and high intention to use. Regarding the clinical utility of the app, we also
hypothesized that the app would allow early detection of low brace adherence, brace-
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related side effects, and psychological distress associated with brace use. Ultimately, we
expect that the early detection of these symptoms with the app-based monitoring system
will allow clinicians to quickly detect and solve unwanted events and thus provide safer
and more effective treatment. To our knowledge, this is the first study to test the feasibility
and clinical utility of telemonitoring adolescents with IS through a multidimensional app.
The present study has some limitations. Regarding the inclusion criteria, only ado-
lescents with a smartphone will participate in the study. Therefore, a small proportion of
patients may not be able to participate in the study. According to recent global statistics
on smartphones, between 80% and 86% of adolescents between 12 and 17 years old own
a smartphone [47,48]. Therefore, sample loss from not owning a smartphone is expected
to be low. This information will be recorded and will be considered in the discussion on
the feasibility of including this methodology for the monitoring of adolescents with IS.
An additional shortcoming lies in the study’s ability to produce reliable findings regarding
treatment effectiveness. Since this is a feasibility study and there will be no control group,
it will be not possible to establish differences between groups and preliminary data on
the clinical utility of the app should be interpreted with caution. However, note that the
current study design is the preferred to provide information on the feasibility and potential
clinical utility of implementing an app-based device for AIS monitoring. This type of study
is important to justify whether a larger-scale randomized controlled trial, which is more
expensive and time consuming, should be conducted [49]. Feasibility studies are crucial
for novel interventions in general and for medical devices and health technology solutions
in particular.
5. Conclusions
While we recognize the limitations mentioned above, if the app-based telemonitoring
of adolescents with IS leads us to the hypothesized results in terms of feasibility and
possible clinical utility, this study will have important clinical implications. Among the
novelties of the present study is the implementation of an app-based EMA system for the
multidimensional monitoring of adolescents with IS. An advantage of implementing this
methodology includes the minimization of problems found in retrospective face-to-face
episodic assessments (i.e., recall bias, poor monitoring that could compromise the safety
of the treatment, and the burden on the physician associated with the time required for
evaluations). Taking recall bias, ecological assessments are known to be more accurate
than retrospective ones [17]. Therefore, the information obtained with these assessments is
more reliable than that obtained from face-to-face appointments where the reliability of
the data depends on the recall capacity of the patients [50]. Regarding treatment safety,
the app will automatically detect the clinical alarms and send them to the physicians.
Therefore, it will allow for timely detection of adverse brace-related symptoms and prompt
management. Consequently, the app-based EMA will allow clinicians to provide more
efficient and personalized treatments. Finally, and in relation to the burden of assessment,
the app monitoring system will allow doctors to receive alarms passively, without the need
to actively call patients at random moments during treatment and without patients having
to travel to clinics. In fact, the entire monitoring process, as explained in this text, can be
performed in an automated way with very little burden for the professionals.
In short, we hope that this new passive telemonitoring method will reduce the current
burden on health care services, as doctors will contact patients only when necessary rather
than routinely calling patients to assess their physical and psychological functioning.
Last but not least, because alarms will occur on an individual level, treatments will become
more personalized as specific responses and adaptations will be possible due to the variety
of brace-related physical and psychological dimensions evaluated in the app.
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Appendix B. Informed Consent
Project title: Improving the quality and safety of adolescent idiopathic scoliosis treatment
Principal investigators: Judith Sanchez Raya
Service: Physical Medicine and Rehabilitation Service at Vall d’Hebron University
Hospital.
Promoters: Universitat Jaume I and Vall d’Hebron University Hospital
Aims: the main objective of this study to monitor adolescents with idiopathic scoliosis
(IS) under brace treatment. Specifically, we will use the free Pain Monitor app to detect the
problems you may experience with brace treatment as early as possible.
With this document we want you to have the correct and sufficient information to
decide whether you want to participate in this study. Read this informed consent carefully.
We will answer any question you may have.
Study procedures: In this study we will propose all adolescent patients with IS
attending the Physical Medicine and Rehabilitation Service of the Vall d’Hebron University
Hospital to use the mobile application. The Physical Medicine and Rehabilitation Service’s
medical team will offer you to participate during your medical appointment. If you accept,
we will ask you and your parent/legal tutor to sign an informed consent form. Before
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downloading the app, we will ask you to answer a few questions about your health on the
Qualtrics online platform. We will require your email address to send you the survey link.
In Qualtrics, you will be asked to use the same random code that we will give you for the
app. Thus, your answers will always be anonymous. We will then help you download the
app into your mobile phone and show you how to use it. Due to the characteristics of the
study, only patients with their own mobile phone will be able to participate. Three months
later, we will ask you to answer the same questions you answered in the first survey on the
Qualtrics platform. We will send you the assessment link again. This will be the end of the
study, but the medical team will continue to monitor you.
It is possible that your answers in the app will generate an alarm that will be sent to
the medical team during the next working day. In that case, if the medical team thinks this
is necessary, they may contact you. However, as alarms do not arrive instantly and will not
always be answered, if you are worried about something related to your treatment, do not
wait for them to contact you. Talk to your parents or legal tutors and do what you would
normally do, such as going to the emergency service, visiting your primary care doctor or
calling the Physical Medicine and Rehabilitation Service.
Protection data: We will store all your answers securely both in the app and in Qualtrics.
This will be done by the research team. They will follow the current security laws to protect
your data (Ley Orgánica 3/2018, de 5 de diciembre, de protección de datos personales y
garantía de los derechos digitales [Spanish law]). Your answers will not be linked to any of
your personal information (name, phone number, or address).
Only the medical team participating in this study will be able to identify you with
your answers using a document that the principal investigator (Dra. Judith Sanchez Raya)
will keep securely. Of all the staff outside the Physical Medicine and Rehabilitation Service,
only the study promoter (Dr. Carlos Suso Ribera), who is in charge of the study, will be
able to know your telephone number if you give him your consent on the informed consent
form. This is important so that he can call you if he detects technical problems with the
app (in no other case). It is possible that the medical team may also call you during the
study (for example, if they receive an alarm from the app).
This study will follow the strictest rules (Organic Law 3/2018 of 5 December and
regulation 2016/679 of the European Parliament and of the Council) to ensure that we
treat your data in the most appropriate way and following the regulation. We will not ask
you for more personal data than necessary. Under no circumstances your personal details
will be given to anyone outside the study, except in the case of a medical emergency that
justifies it or if we are legally bound to do so.
Please note that the data from the app will not be included in your clinical history,
although the data from the Qualtrics survey could be included. In any case, if you have
any questions about your answers in the app or in Qualtrics (for example, if you want to
see them, have them or change them), please contact the study promoter, (Dr. Carlos Suso
Ribera), or the Data Protection Delegate at the Universitat Jaume I (Dra. Diana Castilla,
dolorcronico@uji.es).
The Legal Unit of the Vall d’Hebron University Hospital will resolve your doubts,
complaints, clarifications and suggestions by e-mail: (lopd@vhir.org), or by post: (Paseo
Vall d’Hebrón 119–129, Edificio Mediterránea 2a Planta, 08035 Barcelona). You should be
aware that data cannot be deleted even if you stop participating in the study in order to
guarantee the validity of the research. You can also contact the Data Protection Agency if
you have any further questions.
You have the right to be informed of any important information about your health that is
detected in the study. You have the right to choose whether or not you want this information.
Voluntary participation and right to withdraw the informed consent: You should be
aware that your participation in this study is voluntary. You may decide not to participate
or to change your decision and withdraw your consent at any time. This will not negatively
affect the relationship with your doctor or your treatment.
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Informed Consent: Project title: Improving the quality and safety of adolescent
idiopathic scoliosis treatment
I______________________________________________________________.
I have read the informed consent given to me.
I have been able to ask questions about the study.
I have spoken to: Dra. Judith Sánchez Raya.
I understand that my participation is voluntary and that my data cannot be associated
with an identified or identifiable person because the information that identifies me in the
app and Qualtrics has been replaced by a code.
I understand that my answers to the app are not stored in any official medical record
and my answers in Qualtrics may be included at the discretion of the medical team. There-
fore, if you have any questions about your answers, please contact the study promoter
(Dr. Carlos Suso Ribera; susor@uji.es).
I understand that I can withdraw from the study:
Whenever I want
Without having to provide detailed explanations
Without this negatively influencing my medical care
I voluntarily agree to participate in the study.
I agree that the physicians responsible for this study may contact me in the future if it
is deemed appropriate to add new data to the data collected:
Yes
No
I agree that the promoter of the study and professor at the Universitat Jaume I,
may contact me by phone if an app malfunctioning problem is detected:
Yes
No
Date and signature of the
participant/relative/legal tutor
Date and signature of the researcher
Informed Consent Withdraw
I______________________________________________________________or familiar/
relative/legal tutor (if applicable) of the patient ___________________________ (name and
surname) revoke the above signed informed consent to participate in the study.
This revocation of the informed consent means that from the date on which this
consent is signed, no further medical data may be collected without prejudice to the
conservation of the data resulting from the research previously carried out.
Date and signature of the participant/relative/legal tutor
Appendix C. Alphanumeric Code Linked with Identifying Information






Appendix D. Assessment Protocol
1. Items in the Qualtrics Online Platform
1.1 Items assessed once, in the baseline assessment
Please select your age (in years)
10 (1) . . . 18(9)
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Please select the country in which you born
Spain (163) . . . Zimbabwe (1357)
1.2 Questionnaires administered twice at baseline (before the brace and app use) and
at the end of the study (after 3 months of brace and app use):
• Sobberheim Stress Questionnaire (BSSQ brace) [33,34]. It contains eight items assessing
psychological stress produced by brace in adolescents with IS (i.e., I find it hard to show
my back in public”). Response use a 4-points Likert scale (0 = “most stress” to 3 = “least
stress”). Total scores range from 0 to 24. Higher total scores indicate less stress. Cut-
offs proposed in the original versions are: 0–8 (severe stress), 9–16 (moderate stress),
and 17–24 (mild stress) [34].
• Italian Spine Youth Quality Of Life (ISYQOL) [35,36]. The scale is composed of
20 items. Some of them assess quality of life with respect to back problems and can be
administered to all patients with spinal deformities (spine health domain = 13 items;
“Despite your back problem, do you life a happy life?”). The remaining items are specifically
designed for patients wearing a brace (brace domain = 7 items; “It is uncomfortable to
wear your brace?”). Responses use a 3-point Likert scale (0 = “never”; 1 = “sometimes”;
2 = “often”). Items 5, 6, 10, and 13 are reverse coded. Total scores are converted
into percentages [35]. Final scores range from 0% to 100%, where higher percentages
indicate greater quality of life.
• Scoliosis Research Society-22 (SRS-22) [37,38]. This questionnaire is composed of
22 items that evaluate 5 scoliosis domains, namely function/activity (5 items; “What is
your current level of activity?”), pain (5 items; “Which one of the following best describes the
amount of pain you have experienced over the last month”), self-image/appearance (5 items;
“How do you look in clothes?”), mental health (5 items; “Have you felt calm and peaceful dur-
ing the last 6 months?”), and satisfaction with the treatment (2 items; “which one of the fol-
lowing best describes your pain medication use for back pain?”). Response scales range from
1 = “Severe/All of the time/Very unhappy/Bedridden/Very bad/Very often/Very
poor/None of the time/Severely/Very unsatisfied/Definitely no” to 5 = “None/None
of the time/Very happy/Full activities without restriction/Very good/Never/Very
good/All the time/Very satisfied/Definitely yes”. Higher scores indicate better per-
ceived health status.
• Hospital Anxiety and Depression Scale (HADS) [39,40]. The HADS consists of 14 items
that assess anxiety (seven items; “I feel tense or wound up”) and depression (seven items;
“I still enjoy the things I used to enjoy”). Each item is rated according to a 4-point Likert
scale ranging from 0 = “as much as I always do” to 3 = “not at all”. Total scores range
from 0 to 21 and higher scores represent higher anxiety and depressive symptoms.
Cut-offs are stablished as follows: 0–7 (non-cases), 8–10 (doubtful case), and 11–21
(definite case) [39].
• System Usability Scale (administered only at the end of the study). The SUS evaluates
whether a system is considered to be simple to use and useful (e.g., “I needed to learn
many things before I could start using the system”). It is responded to according to a
5-point Likert scale (1 = “completely disagree” to 5 = “completely agree”). The score of
half of the items has to be reverted so that higher scores indicate higher usability and
acceptability. Then total score is multiplied by 2.5 so that final scores range from 0–100.
1.3 Items used to evaluate app acceptability in the clinicians (all item responses have a
0–4 ranging from “Completely disagree” to “Completely agree”)
To what extent the app was useful for IS management?
To what extent the app increases IS treatment safety?
To what extent the app increases IS treatment effectiveness?
To what extent the app gives me comfort when managing IS?
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To what extent the app is useful for me as a professional?
To what extent the app can be useful for patients with IS?
To what extent the app with alarms is something I want to use in the future?
To what extent the app without alarms is something I want to use in the future?
To what extent the app alarms impacted daily job burden?
To what extent the app has an impact on burden (help patient downloading the app)?
2. Items Assessed with the Pain Monitor Mobile Application
A number of items were adapted from or developed considering well-established
questionnaires (e.g., BSSQ, ISYQOL, SRS-22, HADS) in order to assess relevant brace-
related domains namely side effects of the brace, avoidance behavior, discomfort, and
social support.
Items assessed daily at evening
Please indicate if any of these possible consequences of the brace have been difficult






Teasing by peers or relative ones
None of the above have difficult for me today
Please indicate the intensity of your pain TODAY. Indicate the average for the whole
day between 0 and 10. (Inspired by the SRS-22)
0 No pain ———10 Extreme pain
Please indicate if you feel some of these intense emotions TODAY due to bracing.







I did not feel any of these emotions intensely because of the brace
Please indicate if brace have interfered you in some of these aspects TODAY. You may










Motivation for going out (classroom or leaving home)
None of the above have disturbed me today
When have you been able to wear the brace sin you went to bed yesterday? [Item cre-
ated to assess de degree of nonadherence (mildly vs. severe nonadherent), as recommended
by [51]
Only at morning (8–14 h approx)
Only at afternoon (14–19 h approx)
Only for sleeping (last night)
Today at morning and afternoon, but no for sleeping (last night)
Sleeping (last night) and this morning
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Sleeping (last night) and this afternoon
Sleeping (last night) and all day
I was not able to wear the brace today
Please indicate how much have you avoided talking about your brace today. Rate
from 0 to 10. (Inspired by the BSSQ)
0 I have not avoided it at all ——- 10 I have avoided it a lot
Please indicate how much have you avoided doing things you like or being with
others to hide your brace today. Rate from 0 to 10 (Inspired by the BSSQ)
0 I have not avoided it at all ——- 10 I have avoided it a lot
Indicate from 0 to 10 the degree of discomfort with which you have worn the brace
TODAY. (Inspired by the ISYQOL)
0 No discomfort ——- 10 Maximum discomfort
Select if you have lacked the support of any of these people regarding your brace






I felt supported today
Appendix E. Response to Clinical Alarm
Coping Recommendations When Wearing a Brace
Starting to wear a brace can be difficult. It may lead to questions by others (What is it
that you are wearing?) or even rejection (This that you are wearing is very ugly). Of course,
everyone would prefer not to wear a brace (similar to what happens with orthodontics).
However, if we give a great deal of importance to the criticism of others or to being judged,
the risk is that we will stop doing things that we care about because of this concern and
fear that we will be negatively evaluated by others.
Remember that if you stop doing important things so that other people do not notice
your brace, this will add to your psychological distress. In addition to the suffering
associated with wearing a brace, a second suffering will then be added, that is, the suffering
associated with stopping to participating and enjoying the things and the people you love.
If you have been quitting doing important things for you so that other people do not
notice your brace or if you think that wearing a corset is affecting you a lot, we recommend:
• Remember that the use of a brace is temporary.
• Be compassionate with yourself. Suffering is normal in this situation. Talk about it
with the people you trust.
• Reward yourself. Do not isolate yourself from certain people or activities, as this will
make things even harder for you. Reconnect with what you like by accepting the brace
as a difficulty that you can live with. Try experiencing pleasant emotions with the
activities you like.
• Do not avoid interacting with people or doing activities due to brace or the fear will
become bigger and bigger. You can change and go back to enjoying the things you
like (of course, wearing the corset makes it less pleasant, but still worth it).
• Some discomfort associated with wearing the brace is worth what you earn by partici-
pating in the things you like.
• Do not stop doing things that you like because they can judge you. Connect with what
you like about your activities, with the joy. Accept that, although the brace makes
things more difficult, the activities you like continue to be pleasant.
• Go ahead and participate in activities that you like, activities that can generate well-
being even if your head tells you that they will judge you or that you will have a hard
time. In the end, you may experience an uncomfortable moment (someone who asks
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about the brace or judges you), but it will only be episodic. Going through that short
difficult moment will allow you to enjoy the rest of the activity.
• It is possible that, when you plan to do activities, your head shares difficult thoughts
with you. These may include things like “they will see my corset”, “they will think I am
different”, “they will judge me . . . ”. In those moments, it can be useful to remember
the reasons why you liked this activity before wearing the brace and remember the
good times you have spent doing it.
• Allow yourself not to talk about it when you do not feel like it. Others have the right
to ask, just as you have the right to not answering.
• Wearing a brace is not pleasant, but it is something that will help your health. It is
normal that you do not like it and that you prefer not to wear it. However, accepting
that now is the time to make this effort for your future well-being and understanding
(and welcoming) that this entails difficulties and discomfort will allow you to better
cope with it.
• Allows the corset to be there. Even allow it to be noticed externally. Instead of fighting
against it so that it is not noticed, allowing it to be there and telling yourself that
“nothing devastating happens if it is noticed” will help you to cope better. Of course,
it would be more comfortable not to wear a brace, but you can wear it and at the same
time do the things you like if you give up the fight against it.
• Enjoy who you are now. Do not wait to be that almost unreachable hypothetical
perfect person to get involved in your life and do the things that give you a sense
of fulfillment.
• Think that, even when somebody criticizes or judges you, that is temporary. You do
not have to be liked by everyone at all times and you can do things that you like even
when someone judges you. That judgment is a discomfort that you can carry along
with you in the process of living a meaningful life that is worth living.
• Remember that the important thing is not to do things perfectly or without criticism.
The important thing is to do things with interest and involvement, understanding
and welcoming that things will not always be easy and that you will not always do
things perfectly.
• Think about what YOU want to get out of life, not just what OTHER PEOPLE expect.
• Talk to yourself in a compassionate and kind manner. All of us go through bad
times and make mistakes. What is important is to realize this and to be willing to
make changes.
• Take care of yourself and give yourself messages of appreciation when you make efforts.
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